Bio-Rad Laboratories, Inc. (BIO)
369.14
+13.57
(+3.82%)
USD |
NYSE |
Oct 02, 16:00
368.97
-0.17
(-0.05%)
Pre-Market: 20:00
Bio-Rad Laboratories Gross Profit Margin (Quarterly) : 53.12% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 53.12% |
| March 31, 2026 | 52.25% |
| December 31, 2025 | 49.74% |
| September 30, 2025 | 52.50% |
| June 30, 2025 | 53.01% |
| March 31, 2025 | 53.06% |
| December 31, 2024 | 53.20% |
| September 30, 2024 | 54.78% |
| June 30, 2024 | 55.71% |
| March 31, 2024 | 53.45% |
| December 31, 2023 | 53.72% |
| September 30, 2023 | 53.10% |
| June 30, 2023 | 53.72% |
| March 31, 2023 | 53.59% |
| December 31, 2022 | 54.35% |
| September 30, 2022 | 54.84% |
| June 30, 2022 | 57.16% |
| March 31, 2022 | 57.51% |
| December 31, 2021 | 57.98% |
| September 30, 2021 | 58.57% |
| June 30, 2021 | 56.25% |
| March 31, 2021 | 58.41% |
| December 31, 2020 | 58.26% |
| September 30, 2020 | 56.75% |
| June 30, 2020 | 54.57% |
| Date | Value |
|---|---|
| March 31, 2020 | 55.78% |
| December 31, 2019 | 53.67% |
| September 30, 2019 | 54.76% |
| June 30, 2019 | 53.73% |
| March 31, 2019 | 56.22% |
| December 31, 2018 | 54.05% |
| September 30, 2018 | 52.60% |
| June 30, 2018 | 52.61% |
| March 31, 2018 | 54.81% |
| December 31, 2017 | 55.57% |
| September 30, 2017 | 55.98% |
| June 30, 2017 | 54.17% |
| March 31, 2017 | 54.01% |
| December 31, 2016 | 55.03% |
| September 30, 2016 | 56.54% |
| June 30, 2016 | 55.70% |
| March 31, 2016 | 57.75% |
| December 31, 2015 | 55.62% |
| September 30, 2015 | 56.91% |
| June 30, 2015 | 55.25% |
| March 31, 2015 | 57.13% |
| December 31, 2014 | 53.06% |
| September 30, 2014 | 54.38% |
| June 30, 2014 | 55.37% |
| March 31, 2014 | 54.05% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 40.94% |
| Agilent Technologies, Inc. | 55.48% |
| Danaher Corp. | 57.64% |
| Illumina, Inc. | 66.49% |
| Revvity, Inc. | 50.26% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.15% |
| Return on Assets | 2.20% |
| Return on Invested Capital | 2.63% |
| Profit Margin (Quarterly) | 57.05% |
| Operating Margin (Quarterly) | 11.15% |
| Return on Net Operating Assets | 7.61% |